| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/1997 | WO1997025435A1 Method for preparation of type ii collagen |
| 07/17/1997 | WO1997025430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025427A1 Beta-chemokine, h1305 (mcp-2) |
| 07/17/1997 | WO1997025426A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025424A1 Ob protein receptor and related compositions and methods |
| 07/17/1997 | WO1997025422A1 Cancerous metastasis inhibitor |
| 07/17/1997 | WO1997025421A2 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 07/17/1997 | WO1997025418A1 Angiotensin converting enzyme inhibitors |
| 07/17/1997 | WO1997025414A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025350A1 Use of chemokines for the treatment and prevention of hiv infection |
| 07/17/1997 | WO1997025349A1 Transforming growth factor alpha hiii |
| 07/17/1997 | WO1997025348A1 Regulator of cell proliferation |
| 07/17/1997 | WO1997025347A1 Il-1 receptor interacting protein |
| 07/17/1997 | WO1997025344A1 Clip analogues and autoimmune disease |
| 07/17/1997 | WO1997025343A2 Antithrombotic agents and methods of use |
| 07/17/1997 | WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 07/17/1997 | WO1997025340A1 Human g-protein chemokine receptor hsatu68 |
| 07/17/1997 | WO1997025338A1 Immune cell cytokine |
| 07/17/1997 | WO1997025072A1 Compositions and methods for therapeutic use |
| 07/17/1997 | WO1997025071A2 Immunoconjugate for the treatment of aids |
| 07/17/1997 | WO1997025070A2 Lipophilic peptides for macromolecule delivery |
| 07/17/1997 | WO1997025059A1 Using serine-proteases for acne and inflamed comedones |
| 07/17/1997 | WO1997025057A1 Aqueous prolonged release formulation |
| 07/17/1997 | WO1997025056A1 High affinity mutants of nuclear factor-interleukin 6 and methods of use therefor |
| 07/17/1997 | WO1997025055A1 Nisin in combination with glycerol monolaurate active against helicobacter |
| 07/17/1997 | WO1997025032A2 Monoglyceride compositions and their use against helicobacter |
| 07/17/1997 | WO1997025031A1 Methods of using integrin modulators |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | WO1997012969A3 Fmr1-related protein |
| 07/17/1997 | WO1997012042A3 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242964A1 Immune cell cytokine |
| 07/17/1997 | CA2242908A1 Human g-protein chemokine receptor hsatu68 |
| 07/17/1997 | CA2242711A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | CA2242633A1 Transforming growth factor alpha hiii |
| 07/17/1997 | CA2242514A1 Immunoconjugate for the treatment of aids |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2242385A1 Antithrombotic agents and methods of use |
| 07/17/1997 | CA2242340A1 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | CA2242246A1 Lipophilic peptides for macromolecule delivery |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2240685A1 Aqueous prolonged release formulation |
| 07/16/1997 | EP0784094A1 Ribozyme -snRNA chimeric molecules having a catalytic activity for nuclear RNAs |
| 07/16/1997 | EP0784093A1 Osteoprotegerin |
| 07/16/1997 | EP0784059A1 Antigenic polypeptide of chlamydia pneumoniae |
| 07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof |
| 07/16/1997 | EP0783893A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/16/1997 | EP0783891A1 Remedy for bone diseases |
| 07/16/1997 | EP0783886A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783885A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783693A1 In vitro models of cns function and dysfunction |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783579A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 07/16/1997 | EP0783577A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783574A1 Method for detection of malfolded protein |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783571A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
| 07/16/1997 | EP0783570A1 Finderons and methods of their preparation and use |
| 07/16/1997 | EP0783567A1 Human galactokinase gene |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783525A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 07/16/1997 | EP0783524A1 Peptides and pharmaceutical compositions comprising them |
| 07/16/1997 | EP0783523A1 Gaba a? receptor epsilon subunit |
| 07/16/1997 | EP0783522A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 07/16/1997 | EP0783521A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 07/16/1997 | EP0783519A1 New peptides with immunomodulatory effects |
| 07/16/1997 | EP0783518A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783517A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783516A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783489A1 Aldehyde derivatives as upsteine protease inhibitors |
| 07/16/1997 | EP0783324A1 Cellular immunity-inducing conjugate |
| 07/16/1997 | EP0783322A1 Peptide compositions capable of down regulating an antigen specific immune response |
| 07/16/1997 | EP0783321A1 Vr-2332 viral nucleotide sequence and methods of use |
| 07/16/1997 | EP0783320A1 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 07/16/1997 | EP0783319A1 Muramyl peptide compositions for inhibiting hiv replication |
| 07/16/1997 | EP0783318A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783317A1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 07/16/1997 | EP0783316A1 Synthetic antibiotics |
| 07/16/1997 | EP0783314A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0783305A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783299A1 Compounds and compositions for delivering active agents |
| 07/16/1997 | EP0783298A1 Spray-dried microparticles as therapeutic vehicles |
| 07/16/1997 | EP0728132B1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/16/1997 | EP0717751B1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 07/16/1997 | EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis |
| 07/16/1997 | EP0601154B1 Bpc peptides, their preparation and use |
| 07/16/1997 | EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 07/16/1997 | EP0584125B1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 07/16/1997 | EP0583281B1 Antivenom immunesera |
| 07/16/1997 | EP0527798B1 Method and composition for treating thrombosis |